Capital International Investors Acquires 20,176 Shares of Xenon Pharmaceuticals Inc. - MarketBeat
XENE Stock | USD 38.52 1.10 2.78% |
About 61% of Xenon Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Xenon |
Capital International Investors Acquires 20,176 Shares of Xenon Pharmaceuticals Inc. MarketBeat
Read at news.google.com
Xenon Pharmaceuticals Fundamental Analysis
We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Xenon Pharmaceuticals is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Xenon Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Xenon Pharmaceuticals Related Equities
REPL | Replimune | 16.86 | ||||
VTYX | Ventyx Biosciences | 6.88 | ||||
ANAB | AnaptysBio | 6.50 | ||||
VRDN | Viridian Therapeutics | 6.27 | ||||
MGTX | MeiraGTx Holdings | 5.56 | ||||
IDYA | Ideaya Biosciences | 4.37 | ||||
CRNX | Crinetics Pharmaceuticals | 3.78 | ||||
PCVX | Vaxcyte | 3.36 | ||||
KROS | Keros Therapeutics | 3.23 | ||||
UTHR | United Therapeutics | 2.52 | ||||
ASND | Ascendis Pharma | 2.29 | ||||
MRUS | Merus BV | 0.74 | ||||
CYTK | Cytokinetics | 0.17 | ||||
ACLX | Arcellx | 0.14 | ||||
NUVL | Nuvalent | 0.20 | ||||
INBX | Inhibrx | 0.37 | ||||
LYEL | Lyell Immunopharma | 1.72 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
KRON | Kronos Bio | 1.98 | ||||
DYN | Dyne Therapeutics | 4.33 |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |